Predicting Hearing Loss in Testicular Cancer Patients after Cisplatin-Based Chemotherapy

SIMPLE SUMMARY: To our knowledge, this is the first study that presents a machine learning setup incorporating genetics and clinical factors to predict hearing loss in a large and fairly unique cohort of testicular cancer patients, with follow-up data examining long-range side effects of chemotherap...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia, Sara L., Lauritsen, Jakob, Christiansen, Bernadette K., Hansen, Ida F., Bandak, Mikkel, Dalgaard, Marlene D., Daugaard, Gedske, Gupta, Ramneek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417151/
https://www.ncbi.nlm.nih.gov/pubmed/37568739
http://dx.doi.org/10.3390/cancers15153923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417151/
https://www.ncbi.nlm.nih.gov/pubmed/37568739
http://dx.doi.org/10.3390/cancers15153923

Ejemplares similares